WallStreetZenWallStreetZen

NASDAQ: CRNX
Crinetics Pharmaceuticals Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Crinetics Pharmaceuticals revenue was $760.00k for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $361.0k, up Infinity% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CRNX annual revenue was $1.0M, with -74.1% growth year-over-year.

CRNX past revenue growth

How has CRNX's revenue growth performed historically?

Company
-61.5%
Industry
1,663.15%
Market
38.12%
CRNX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CRNX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CRNX's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CRNX revenue history

Current Revenue
$760.0k
Current Earnings
-$328.3M
Current Profit Margin
-43,191.1%

Be the first to know when CRNX announces revenue.

CRNX Revenue History By Year

CRNX Yearly RevenueCRNX RevenueCRNX ChangeCRNX Revenue Growth
2024-12-31$1.04M-$2.97M-74.11%
2023-12-31$4.01M-$724.00k-15.28%
2022-12-31$4.74M$3.66M+339.42%
2021-12-31$1.08M$1.01M+1,418.31%
2020-12-31$71.00k-$1.12M-94.05%
2019-12-31$1.19M-$1.24M-50.86%
2018-12-31$2.43M$383.00k+18.73%
2017-12-31$2.05M$1.46M+247.20%
2016-12-31$589.00kN/AN/A

1 of 1

Crinetics Pharmaceuticals Revenue FAQ

What was CRNX's revenue last quarter?

On Invalid Date, Crinetics Pharmaceuticals (NASDAQ: CRNX) reported Q1 2025 revenue of $361.00 thousand up 43.59% year over year. In the same quarter last year, Crinetics Pharmaceuticals's revenue was $640.00 thousand.

What was Crinetics Pharmaceuticals's revenue in 2024?

Crinetics Pharmaceuticals's annual revenue for the twelve months ending Dec 31, 2024 was $1.04 million, a 74.11% decrease year over year.

How much does Crinetics Pharmaceuticals make in a day?

Based on Crinetics Pharmaceuticals annual revenue for the past five years, CRNX makes an average of $5,993.42 per day.

What was Crinetics Pharmaceuticals's annual revenue growth in the past year?

As of Q2 2025, Crinetics Pharmaceuticals's revenue has grown -61.5% year over year. This is 1,724.65 percentage points lower than the US Biotechnology industry revenue growth rate of 1,663.15%. Crinetics Pharmaceuticals's revenue in the past year totaled $760.00 thousand.

How much does Crinetics Pharmaceuticals make in a year?

Crinetics Pharmaceuticals's revenue by year for the past five years is:
  • Crinetics Pharmaceuticals's revenue for the twelve months ending Dec 31, 2024 was $1.04 million, a 74.11% decrease year over year.
  • Crinetics Pharmaceuticals's annual revenue for Dec 31, 2023 was $4.01 million, a 15.28% decrease from 2022.
  • Crinetics Pharmaceuticals's annual revenue for 2022 was $4.74 million, a 339.42% increase from 2021.
  • Crinetics Pharmaceuticals's annual revenue for 2021 was $1.08 million, a 1,418.31% increase from 2020.
  • Crinetics Pharmaceuticals's annual revenue for 2020 was $71.00 thousand, a 94.05% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.